1 / 2

Buy lenvima tablet

Lenvima is an approved medicine that contains lenvatinib. It is used to treat different kinds of cancers. This medication is mainly prescribed to patients diagnosed with Hepatocellular Carcinoma (liver cancer), Renal Cell Carcinoma (kidney cancer), and Differentiated Thyroid Cancer. Purchase the lenvima tablet at a 30% discount on Magicine Pharma.<br><br>

15032
Télécharger la présentation

Buy lenvima tablet

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. lenvima tablet Overview Lenvima is an approved medicine that contains lenvatinib. It is used to treat different kinds of cancers. This medication is mainly prescribed to patients diagnosed with Hepatocellular Carcinoma (liver cancer), Renal Cell Carcinoma (kidney cancer), and Differentiated Thyroid Cancer. Purchase the lenvima tablet at a 30% discount on Magicine Pharma.

  2. Generic Name:- Lenvatinib Manufacturer:- Eisai Dosage Form:- Capsule Strength:- 10mg Composition:- Lenvatinib Packaging:- 10 capsule (10/strip) Indication:- Kidney, Thyroid, and Liver cancer Storage:- Store at room temperature. Pharmacodynamics Of Lenvima (Lenvatinib) Lenvatinib is a receptor tyrosine kinase receptor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1, VEGFR2, VEGFR3. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet-derived growth factor receptor alpha (PDGFRα), KIT, and RET. After the oral administration, the effect of this medicine can be observed in 1 to 4 hours.

More Related